These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24968885)

  • 21. CHADS2 and CHA2DS2-VASc scores for prediction of immediate and late stroke after coronary artery bypass graft surgery.
    Biancari F; Asim Mahar MA; Kangasniemi OP
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1304-11. PubMed ID: 23253529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.
    Chao TF; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Hsieh MH; Chen SA
    Can J Cardiol; 2014 Apr; 30(4):405-12. PubMed ID: 24582725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of CHADS2, CHA2DS2-VASc, and R2CHADS2 scores with left atrial dysfunction in patients with coronary heart disease (from the Heart and Soul study).
    Azarbal F; Welles CC; Wong JM; Whooley MA; Schiller NB; Turakhia MP
    Am J Cardiol; 2014 Apr; 113(7):1166-72. PubMed ID: 24507169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation.
    Lip GY
    Am J Med; 2011 Feb; 124(2):111-4. PubMed ID: 20887966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
    Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
    Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation.
    Marcucci M; Nobili A; Tettamanti M; Iorio A; Pasina L; Djade CD; Franchi C; Marengoni A; Salerno F; Corrao S; Violi F; Mannucci PM;
    Eur J Intern Med; 2013 Dec; 24(8):800-6. PubMed ID: 24035703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.
    Jover E; Roldán V; Gallego P; Hernández-Romero D; Valdés M; Vicente V; Lip GY; Marín F
    Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):627-33. PubMed ID: 22609214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin versus warfarin in atrial fibrillation: decision analysis may help patients' choice.
    Romero-Ortuno R; O'Shea D
    Age Ageing; 2012 Mar; 41(2):250-4. PubMed ID: 22156597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stratification with CHA2DS2-VASc score is better than CHADS2 score in reducing ischemic stroke risk in patients with atrial fibrillation.
    Pieri A; Lopes TO; Gabbai AA
    Int J Stroke; 2011 Oct; 6(5):466. PubMed ID: 21951414
    [No Abstract]   [Full Text] [Related]  

  • 30. Which risk score best predicts perioperative outcomes in nonvalvular atrial fibrillation patients undergoing noncardiac surgery?
    van Diepen S; Youngson E; Ezekowitz JA; McAlister FA
    Am Heart J; 2014 Jul; 168(1):60-7.e5. PubMed ID: 24952861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality after ground-level fall in the elderly patient taking oral anticoagulation for atrial fibrillation/flutter: a long-term analysis of risk versus benefit.
    Inui TS; Parina R; Chang DC; Inui TS; Coimbra R
    J Trauma Acute Care Surg; 2014 Mar; 76(3):642-9; discussion 649-50. PubMed ID: 24553530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.
    Coppens M; Eikelboom JW; Hart RG; Yusuf S; Lip GY; Dorian P; Shestakovska O; Connolly SJ
    Eur Heart J; 2013 Jan; 34(3):170-6. PubMed ID: 23018151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.
    Overvad TF; Larsen TB; Albertsen IE; Rasmussen LH; Lip GY
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1619-29. PubMed ID: 24215192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.
    Guo Y; Lip GY; Apostolakis S
    Hosp Pract (1995); 2013 Feb; 41(1):71-8. PubMed ID: 23466969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of comorbidities among patients with atrial fibrillation.
    LaMori JC; Mody SH; Gross HJ; daCosta DiBonaventura M; Patel AA; Schein JR; Nelson WW
    Ther Adv Cardiovasc Dis; 2013 Apr; 7(2):53-62. PubMed ID: 23090783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical risk stratification schemes to predict thromboembolism in patients with atrial fibrillation].
    Hirai T; Inoue H
    Nihon Rinsho; 2013 Jan; 71(1):105-11. PubMed ID: 23631180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
    Lip GY
    Eur Heart J; 2013 Apr; 34(14):1041-9. PubMed ID: 23257951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of coronary artery disease severity using CHADS2 and CHA2DS2-VASc scores and a newly defined CHA2DS2-VASc-HS score.
    Cetin M; Cakici M; Zencir C; Tasolar H; Baysal E; Balli M; Akturk E
    Am J Cardiol; 2014 Mar; 113(6):950-6. PubMed ID: 24444782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardioembolic stroke in atrial fibrillation and new anticoagulation criteria: a therapeutic dare].
    Perez-Ortega I; Moniche-Alvarez F; Jimenez-Hernandez MD; Gonzalez-Marcos JR
    Rev Neurol; 2012 Jul; 55(2):74-80. PubMed ID: 22760766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stroke risk stratification in a "real-world" elderly anticoagulated atrial fibrillation population.
    Poli D; Lip GY; Antonucci E; Grifoni E; Lane D
    J Cardiovasc Electrophysiol; 2011 Jan; 22(1):25-30. PubMed ID: 20653814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.